argenx SE reported $286.9M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
AstraZeneca USD 3.13B 275M Jun/2025
Galapagos EUR -156367000 175.4M Mar/2025
Genmab DKK 423M 179M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 144M 144M Jun/2024
Qiagen NV USD 126.82M 7.27M Jun/2025
UCB EUR 1.22B 781M Dec/2024